Artificial intelligence (AI) software developer Caption Health has received U.S. Food and Drug Administration (FDA) clearance for a new update to its Caption Guidance echocardiography image acquisition software aimed at helping in the fight against the COVID-19 pandemic.
The new version of Caption Guidance is designed to enable frontline healthcare workers without specialized echocardiography training to capture cardiac images at the point of care, as well as decrease personnel exposure to COVID-19, according to the vendor. It provides 88% more types of guidance, improved algorithm performance, and optimized workflow, the company said.
The FDA cleared the updated version of Caption Guidance after only 25 days, Caption Health said.
